Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance
Abstract Pulmonary hypertension (PH) is a prevalent comorbidity associated with COPD accountable for increased mortality, exacerbation frequency, and progressive clinical course. Studies examining pulmonary vasodilator therapy in COPD-PH have shown mixed results, likely due to the heterogenous natur...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMC
2026-02-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-026-04203-4 |
| Tags: |
No Tags, Be the first to tag this record!
|